Clinical Research Directory

Inclusion Criteria: * Patients undergoing HDL between 18 and 60 years old. * Non-gender specific. * American Association of Anesthesiologist Risk Assessment (ASA) ≤ 2. * Body Mass Index (BMI) ≥20 and ≤ 32 kg/m2. * Patients with any degree of clinically evident cellulite in any body area. * Patients with prior liposuction procedures with any degree of fibrosis in any body area. * Patients undergoing additional procedures such as, but not limited to: Rhinoplasty, Mammaplasty, Mastopexy, mini tummy tuck, full tummy tuck, brachioplasty, thighplasty, fat grafting. The procedure could not be related to the treatment of fibrosis or cellulite. Exclusion Criteria: * Patients requiring SQ fat grafting for the amendment of any contour irregularity. * Patients requiring other devices/drugs for skin contraction and/or cellulite treatment for the next 6 months (RF, US, Enzymes, etc.). * Patients undergoing Face Lift procedures. * Patients with any history of abnormal scarring and/or hypertrophic scars and or keloids. * Patients with Caprini score ≥ 8. * Patients with past medical history of connective tissue disease with active disease and/or recent relapse. * Patients with past medical history thromboembolic disease or any other condition with an increased risk of coagulopathy (i.e., SLE, RA, APS). * Patients using aspirin or any anticoagulant within 14 days and 5 days prior to surgery, respectively. * Patients with a PMH of epilepsy or any epileptic syndrome and or vascular disease. * Patients with any chronic disease non-compliant with treatment or non-adequately controlled. * Positive pregnancy test or planning on getting pregnant in the next 6 months. * Patients with fever or any other symptoms/signs of infection. * Active smokers or chronic smokers with recent quit (≤ 4-8 weeks). * Patients with prothrombin time (PT) and/or activated partial thromboplastin time (aPTT) \>1.5 times baseline.